Alimera Sciences
ALIM
ALIM was delisted on the 13th of September, 2024.
19 hedge funds and large institutions have $7.99M invested in Alimera Sciences in 2020 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 0 reducing their positions, and 4 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
34% more capital invested
Capital invested by funds: $5.95M → $7.99M (+$2.03M)
5% less funds holding
Funds holding: 20 → 19 (-1)
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$1.86M |
| 2 |
Renaissance Technologies
New York
|
+$209K |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
+$19.2K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$16.1K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$12.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACA
Avoro Capital Advisors
New York
|
-$2.02M |
| 2 |
DM
Deerfield Management
New York
|
-$332K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$1K |
ALIM Hedge Fund Activity: Q4 2020 in Review
19 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Alimera Sciences (ALIM) for Q4 2020, worth a combined $7.99M — up 34% from $5.95M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of ALIM and 3 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 6 added.
The largest buyer was Morgan Stanley, adding an estimated $1.86M. The largest seller was Avoro Capital Advisors, exiting entirely with an estimated $2.02M sold.
- 19 institutional investors held Alimera Sciences (ALIM) as of Q4 2020, down from 20 in Q3 2020.
- Funds reported $7.99M of Alimera Sciences stock for Q4 2020, up 34% quarter-over-quarter.
- 3 funds opened new Alimera Sciences positions in Q4 2020 and 4 closed out, a net change of -1 holder.
- The largest Alimera Sciences buyer in Q4 2020 was Morgan Stanley, an estimated $1.86M added.
- The largest Alimera Sciences seller in Q4 2020 was Avoro Capital Advisors, an estimated $2.02M sold.
Based on aggregated 13F filings for Q4 2020.